Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov:510:717-722.
doi: 10.1016/j.cca.2020.09.018. Epub 2020 Sep 16.

SARS-CoV-2 identification and IgA antibodies in saliva: One sample two tests approach for diagnosis

Affiliations

SARS-CoV-2 identification and IgA antibodies in saliva: One sample two tests approach for diagnosis

Ada Aita et al. Clin Chim Acta. 2020 Nov.

Abstract

Aim: This study aims to verify whether standardized saliva collection is suitable for SARS-CoV-2 molecular detection and IgA measurement.

Methods: 43 COVID-19 inpatients and 326 screening subjects underwent naso-pharyngeal (NP)-swab and saliva collection (Salivette). Inpatients also underwent repeated blood collections to evaluate inflammation and organs involvement. In all patients and subjects, SARS-CoV-2 (gene E) rRT-PCR was undertaken in saliva and NP-swabs. Salivary IgA and serum IgA, IgG, IgM were measured on inpatients' samples.

Results: NP-swabs and saliva were both SARS-CoV-2 positive in 7 (16%) or both negative in 35 (82%) out of 43 patients successfully included in the study. NP-swabs and saliva results did not perfectly match in one patient (saliva positive, NP-swab negative). Positive molecular results were significantly associated with disease duration (p = 0.0049). 326/326 screening subjects were SARS-CoV-2 negative on both NP-swabs and saliva. Among the 27 saliva samples tested for IgA, 18 were IgA positive. Salivary IgA positivity was associated with pneumonia (p = 0.002) and CRP values (p = 0.0183), not with other clinical and molecular data, or with serum immunoglubulins.

Conclusions: A standardized saliva collection can be adopted to detect SARS-CoV-2 infection in alternative to NP-swabs. Preliminary data on salivary IgA support the use of saliva also for patient monitoring.

Keywords: Naso-pharyngeal swab; SARS-CoV-2; Saliva; Salivary IgA.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
The correlation between threshold cycle (Ct) values obtained with rRT-PCR and SARS-CoV-2 copy number/μl (ddPCR). Correlation between threshold cycles (Ct) and the copy number/μl obtained with ddPCR (expressed in log2). Six SARS-CoV-2 positive naso-pharyngeal swabs (open circles) and corresponding saliva data (dots) are shown.
Fig. 2
Fig. 2
The correlation between salivary IgA and biochemical and haematological markers. The correlation between salivary IgA and biochemical and haematological parameters. The upper panel shows the correlation between salivary IgA positive or negative findings and CRP values obtained at admission and enrolment. The lower panel shows the correlation between salivary IgA and white blood cell count at admission and enrolment.

Similar articles

Cited by

References

    1. Coronavirus disease 2019 (COVID-19) in the EU/EEA and the UK– ninth update, 2020, 1–50.
    1. Leung K., Wu J.T., Liu D.i., Leung G.M. First-wave COVID-19 transmissibility and severity in China outside Hubei after control measures, and second-wave scenario planning: a modelling impact assessment. The Lancet. 2020;395(10233):1382–1393. - PMC - PubMed
    1. C.B.E.M. Reusken, E.K. Broberg, B. Haagmans, A. Meijer, V.M. Corman, A. Papa, et al., Laboratory readiness and response for novel coronavirus (2019-nCoV) in expert laboratories in 30 EU/EEA countries, January 2020, Euro Surveill. 25 (6) (2020). http://doi.org/10.2807/1560-7917.ES.2020.25.6.2000082. - PMC - PubMed
    1. World Health Organization (WHO) Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases. https://apps.who.int/iris/handle/10665/330676, 2020 (accessed 15 June 2020).
    1. Loeffelholz M.J., Tang Y.-W. Laboratory diagnosis of emerging human coronavirus infections - the state of the art. Emerg. Microbes Infect. 2020;9(1):747–756. doi: 10.1080/22221751.2020.1745095. - DOI - PMC - PubMed

Substances